We are live on ! Find out more
CATX icon

Perspective Therapeutics

38 hedge funds and large institutions have $3.94M invested in Perspective Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $3.84M → $3.94M (+$105K)

0% more funds holding

Funds holding: 3838 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.02% less ownership

Funds ownership: 1.07%1.05% (-0.02%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
38
Holders Change
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
7
Closed
4
Calls
Puts
Net Calls
Net Calls Change

CATX Hedge Fund Activity: Q2 2020 in Review

38 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2020, worth a combined $3.94M — up 2.7% from $3.84M a quarter earlier.

Fund positioning in CATX was balanced in Q2 2020: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $253K. The largest seller was EAM Investors, cutting an estimated $496K.

  • 38 institutional investors held Perspective Therapeutics (CATX) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $3.94M of Perspective Therapeutics stock for Q2 2020, up 2.7% quarter-over-quarter.
  • 4 funds opened new Perspective Therapeutics positions in Q2 2020 and 4 closed out, a net change of 0 holders.
  • The largest Perspective Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $253K added.
  • The largest Perspective Therapeutics seller in Q2 2020 was EAM Investors, an estimated $496K sold.

Based on aggregated 13F filings for Q2 2020.